Age-dependent effects of initial exposure to nicotine on serotonin neurons

Neuroscience

Volumn 179, Issue , 2011, Pages 1-8

  Bang, S J ^a,b   Commons, K G ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Addiction; Adolescence; Raphe; Serotonin

Indexed keywords

NICOTINE; PROTEIN FOS; TRYPTOPHAN HYDROXYLASE;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; EXPOSURE; MALE; MEDIAN RAPHE NUCLEUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; TOBACCO DEPENDENCE;

AGE FACTORS; ANIMALS; BEHAVIOR, ADDICTIVE; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; NICOTINE; NICOTINIC AGONISTS; PROTO-ONCOGENE PROTEINS C-FOS; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 79952623568     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.01.032     Document Type: Article

References (59)

1. Abrams J.K., Johnson P.L., Hay-Schmidt A., Mikkelsen J.D., Shekhar A., Lowry C.A. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience 2005, 133(4):983-997.
2. Adriani W., MacrÌ S., Pacifici R., Laviola G. Peculiar vulnerability to nicotine oral self-administration in mice during early adolescence. Neuropsychopharmacology 2002, 27(2):212-224.
3. Adriani W., Granstrem O., Macri S., Izykenova G., Dambinova S., Laviola G. Behavioral and neurochemical vulnerability during adolescence in mice: studies with nicotine. Neuropsychopharmacology 2004, 29:869-878.
4. Adriani W., Spijker S., Deroche-Gamonet V., Laviola G., Le Moal M., Smit A.B., Piazza P.V. Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. J Neurosci 2003, 23:4712-4716.
5. Andén N.E., Dahlström A., Fuxe K., Larsson K. Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon. Life Sci 1965, 4(13):1275-1279.
6. Awtry T.L., Werling L.L. Acute and chronic effects of nicotine on serotonin uptake in prefrontal cortex and hippocampus of rats. Synapse 2003, 50(3):206-211.
7. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 1978, 179(3):641-667.
8. Bar-Peled O., Gross-Isseroff R., Ben-Hur H., Hoskins I., Groner Y., Biegon A. Fetal human brain exhibits a prenatal peak in the density of serotonin 5-HT1A receptors. Neurosci Lett 1991, 127(2):173-176.
9. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38(8):1083-1152.
10. Belluzzi J.D., Lee A.G., Oliff H.S., Leslie F.M. Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology (Berl) 2004, 174(3):389-395.
11. Breslau N., Peterson E.L. Smoking cessation in young adults: age at initiation of cigarette smoking and other suspected influences. Am J Public Health 1996, 86(2):214-220.
12. Carboni E., Acquas E., Leone P., Perezzani L., Di Chiara G. 5-HT3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning. Eur J Pharmacol 1988, 151(1):159-160.
13. Cheeta S., Kenny P.J., File S.E. The role of 5-HT1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration. Eur J Neurosci 2000, 12(10):3797-3802.
14. Cheeta S., Irvine E.E., Kenny P.J., File S.E. The dorsal raphé nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology (Berl) 2001, 155(1):78-85.
15. Chen J., Millar W.J. Age of smoking initiation: implications for quitting. Health Rep 1998, 9(4):39-46. (Eng); 39-48 (Fre).
16. Cippitelli A., Damadzic R., Hansson A.C., Singley E., Sommer W.H., Eskay R., Thorsell A., Heilig M. Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking. Psychopharmacology (Berl) 2010, 208(3):417-426.
17. Collins S.L., Wade D., Ledon J., Izenwasser S. Neurochemical alterations produced by daily nicotine exposure in periadolescent vsadult male rats. Eur J Pharmacol 2004, 502(1-2):75-85.
18. Commons K.G., Connolley K.R., Valentino R.J. A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology 2003, 28(2):206-215.
19. Curran T., Morgan J.I. Fos: an immediate-early transcription factor in neurons. J Neurobiol 1995, 26(3):403-412.
20. Dayas C.V., Liu X., Simms J.A., Weiss F. Distinct patterns of neural activation associated with ethanol seeking: effects of naltrexone. Biol Psychiatry 2007, 61(8):979-989.
21. Dillon K.A., Gross-Isseroff R., Israeli M., Biegon A. Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol. Brain Res 1991, 554(1-2):56-64.
22. Dyck R.H., Cynader M.S. Autoradiographic localization of serotonin receptor subtypes in cat visual cortex: transient regional, laminar, and columnar distributions during postnatal development. J Neurosci 1993, 13(10):4316-4338.
23. Hollis J.H., Evans A.K., Bruce K.P., Lightman S.L., Lowry C.A. Lipopolysaccharide has indomethacin-sensitive actions on Fos expression in topographically organized subpopulations of serotonergic neurons. Brain Behav Immun 2006, 20(6):569-577.
24. Imai H., Steindler D.A., Kitai S.T. The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J Comp Neurol 1986, 243(3):363-380.
25. Kandel D.B., Chen K. Extent of smoking and nicotine dependence in the United States: 1991-1993. Nicotine Tob Res 2000, 2(3):263-274.
26. Kenny P.J., File S.E., Neal M.J. Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release. J Neurochem 2000, 75(6):2409-2414.
27. Kenny P.J., File S.E., Rattray M. Nicotine regulates 5-HT(1A) receptor gene expression in the cerebral cortex and dorsal hippocampus. Eur J Neurosci 2001, 13(6):1267-1271.
28. Koob G.F., Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997, 278(5335):52-58.
29. Levin E.D., Lawrence S., Petro A., Horton K., Seidler F.J., Slotkin T.A. Increased nicotine self-administration following prenatal exposure in female rats. Pharmacol Biochem Behav 2006, 85(3):669-674.
30. Li X., Rainnie D.G., McCarley R.W., Greene R.W. Presynaptic nicotinic receptors facilitate monoaminergic transmission. J Neurosci 1998, 18(5):1904-1912.
31. Matta S.G., Balfour D.J., Benowitz N.L., Boyd R.T., Buccafusco J.J., Caggiula A.R., Craig C.R., Collins A.C., Damaj M.I., Donny E.C., Gardiner P.S., Grady S.R., Heberlein U., Leonard S.S., Levin E.D., Lukas R.J., Markou A., Marks M.J., McCallum S.E., Parameswaran N., Perkins K.A., Picciotto M.R., Quik M., Rose J.E., Rothenfluh A., Schafer W.R., Stolerman I.P., Tyndale R.F., Wehner J.M., Zirger J.M. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 2007, 190(3):269-319.
32. Michelsen K.A., Schmitz C., Steinbusch H.W. The dorsal raphe nucleus-from silver stainings to a role in depression. Brain Res Rev 2007, 55(2):329-342.
33. Mihailescu S., Guzmán-Marín R., Domínguez Mdel C., Drucker-Colín R. Mechanisms of nicotine actions on dorsal raphe serotoninergic neurons. Eur J Pharmacol 2002, 452(1):77-82.
34. Mihailescu S., Palomero-Rivero M., Meade-Huerta P., Maza-Flores A., Drucker-Colín R. Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur J Pharmacol 1998, 360(1):31-36.
35. Paxinos G., Watson C. The rat brain in stereotaxic coordinates-the new coronal set 2005, Academic Press, Sydney. 5th ed.
36. Petrov T., Krukoff T.L., Jhamandas J.H. The hypothalamic paraventricular and lateral parabrachial nuclei receive collaterals from raphe nucleus neurons: a combined double retrograde and immunocytochemical study. J Comp Neurol 1992, 318(1):18-26.
37. Petrov T., Krukoff T.L., Jhamandas J.H. Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat. Cell Tissue Res 1994, 277(2):289-295.
38. Plaza-Zabala A., Martín-García E., de Lecea L., Maldonado R., Berrendero F. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J Neurosci 2010, 30(6):2300-2310.
39. Ribeiro E.B., Bettiker R.L., Bogdanov M., Wurtman R.J. Effects of systemic nicotine on serotonin release in rat brain. Brain Res 1993, 621:311-318.
40. Roche M., Commons K.G., Peoples A., Valentino R.J. Circuitry underlying regulation of the serotonergic system by swim stress. J Neurosci 2003, 23(3):970-977.
41. Schramm-Sapyta N.L., Walker Q.D., Caster J.M., Levin E.D., Kuhn C.M. Are adolescents more vulnerable to drug addiction than adults?. Evidence from animal models. Psychopharmacology (Berl) 2009, 206(1):1-21.
42. Seth P., Cheeta S., Tucci S., File S.E. Nicotinic-serotonergic interactions in brain and behaviour. Pharmacol Biochem Behav 2002, 71(4):795-805.
43. Shearman E., Fallon S., Sershen H., Lajtha A. Nicotine-induced monoamine neurotransmitter changes in the brain of young rats. Brain Res Bull 2008, 76(6):626-639.
44. Shram M.J., Lê A.D. Adolescent male Wistar rats are more responsive than adult rats to the conditioned rewarding effects of intravenously administered nicotine in the place conditioning procedure. Behav Brain Res 2010, 206(20):240-244.
45. Shram M.J., Funk D., Li Z., Lê A.D. Periadolescent and adult rats respond differently in tests measuring the rewarding and aversive effects of nicotine. Psychopharmacology (Berl) 2006, 186(2):201-208.
46. Slotkin T.A., Tate C.A., Cousins M.M., Seidler F.J. Prenatal nicotine exposure alters the responses to subsequent nicotine administration and withdrawal in adolescence: serotonin receptors and cell signaling. Neuropsychopharmacology 2006, 31(11):2462-2475.
47. Summers K.L., Lippiello P., Giacobini E. A microdialysis study of the effects of the nicotinic agonist RJR-2403 on cortical release of acetylcholine and biogenic amines. Neurochem Res 1996, 21(10):1181-1186.
48. Taioli E., Wynder E.L. Effect of the age at which smoking begins on frequency of smoking in adulthood. N Engl J Med 1991, 325(13):968-969.
49. Torres O.V., Tejeda H.A., Natividad L.A., O'Dell L.E. Enhanced vulnerability to the rewarding effects of nicotine during the adolescent period of development. Pharmacol Biochem Behav 2008, 90(4):658-663.
50. Toth E., Sershen H., Hashim A., Vizi E.S., Lajtha A. Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid. Neurochem Res 1992, 17:265-271.
51. Turner D.M. Influence of route of administration on metabolism of [14C]nicotine in four species. Xenobiotica 1975, 5(9):553-561.
52. Van Bockstaele E.J., Biswas A., Pickel V.M. Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens. Brain Res 1993, 624(1-2):188-198.
53. van der Kooy D., Hattori T. Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat. Brain Res 1980, 186(1):1-7.
54. Vastola B.J., Douglas L.A., Varlinskaya E.I., Spear L.P. Nicotine-induced conditioned place preference in adolescent and adult rats. Physiol Behav 2002, 77(1):107-114.
55. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 1991, 313(4):643-668.
56. Vertes R.P., Fortin W.J., Crane A.M. Projections of the median raphe nucleus in the rat. J Comp Neurol 1999, 407(4):555-582.
57. Wilmouth C.E., Spear L.P. Adolescent and adult rats' aversion to flavors previously paired with nicotine. Ann N Y Acad Sci 2004, 1021:462-464.
58. Xu Z., Seidler F.J., Ali S.F., Slikker W., Slotkin T.A. Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res 2001, 914(1-2):166-178.
59. Xu Z., Seidler F.J., Cousins M.M., Slikker W., Slotkin T.A. Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. Brain Res 2002, 951(2):280-292.